Please use this identifier to cite or link to this item:
|dc.title||Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells|
|dc.identifier.citation||Wong, S.C.H.,Yu, H.,Moochhala, S.M.,So, J.B.Y. (2003-01). Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells. Anticancer Research 23 (1 A) : 465-469. ScholarBank@NUS Repository.|
|dc.description.abstract||Background: Antisense telomerase RNA (anti-hTR) coupled with 2′, 5′-linked tetraadenylate (2-5A) shows an inhibitory effect on cell growth and induces apoptosis in certain kinds of cancer. This experiment examined the anti-hTR effect on gastric and colorectal cancer cells. Materials and Methods: Gastric cancer cells CRL-5822, CRL-5971 and colorectal cancer cells HTB-38, CCL-247 were treated with repeated doses of anti-hTR. Cell growth and cell cycle parameters were analysed. Telomerase activity was measured by TRAP assay. Control oligonucleotides and normal fibroblast were used as control. Results: After two doses of anti-hTR, the cell viability for CRL-5822, CRL-5971, HTB-38 and CCL-247 cells was reduced to 15%, 12%, 37% and 37%, respectively. The DNA histogram showed cells arrested at the G2 / M - phase and the sub-G1 peak found indicated that apoptosis had occurred. Conclusion: Anti-hTR demonstrated inhibition of cell growth and cell cycle arrest on gastric and colorectal cancer cells through a telomerase regulation pathway. Its specificity towards cancerous tissues but not normal tissues suggested a potential for anti-cancer therapy.|
|dc.subject||Cell cycle arrest|
|dc.contributor.department||NATIONAL UNIVERSITY MEDICAL INSTITUTES|
|Appears in Collections:||Staff Publications|
Show simple item record
Files in This Item:
There are no files associated with this item.
checked on Mar 28, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.